• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cell & Gene Therapy

Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

two arrows pointing different directions
Pharma

FDA to reconsider rejected cell therapy. Could uniQure be next?

As the FDA walks back its previous criticism of Ebvallo's single-arm trial, there's hope for a reversal for uniQure's gene therapy, too.
Angus Liu May 7, 2026 10:40am
Trust in block letters

Bayer diagnoses how to build trust in cell and gene therapies

May 6, 2026 10:45am
Asia

Sun-Organon, Astellas, BeOne—Fierce Pharma Asia

May 1, 2026 8:43am
hearing audio waves

Regeneron ushers in new era with inaugural gene therapy approval

Apr 23, 2026 3:22pm
Gene Therapy of treatment and adjustment of DNA

Neurogene taps new commercial lead

Apr 20, 2026 8:50am
Roche

Roche to launch another Elevidys study, eying EU approval

Apr 16, 2026 10:06am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings